Literature DB >> 3436356

Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture.

W V Welshons1, V C Jordan.   

Abstract

When human breast cancer-derived MCF-7 cells were maintained in low estrogen medium (phenol red-free), the cells adapted to grow without added estrogen, but growth could be inhibited by antiestrogen in the medium. Estrogen-stimulated progesterone receptor levels remained basal but could be stimulated by estradiol. Estrogen receptor content increased steadily during adaptation, which may model the increasing levels of estrogen receptor observed in breast cancer with increasing patient age. The mechanism of the adaptation to low estrogen medium is unclear; however, cell lines such as MCF-7 may need to be cultured in the presence of an estrogen such as phenol red in order to maintain a stable estrogen-sensitive phenotype. On the other hand, maintenance of estrogen-dependent cells in low estrogen media may convert them to dependence on factors which are not currently understood. This may ultimately increase their value as models of hormone action.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436356     DOI: 10.1016/0277-5379(87)90062-9

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  35 in total

1.  Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society.

Authors:  R Thomas Zoeller; T R Brown; L L Doan; A C Gore; N E Skakkebaek; A M Soto; T J Woodruff; F S Vom Saal
Journal:  Endocrinology       Date:  2012-06-25       Impact factor: 4.736

2.  Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.

Authors:  V Craig Jordan; Ramona Curpan; Philipp Y Maximov
Journal:  J Natl Cancer Inst       Date:  2015-04-02       Impact factor: 13.506

Review 3.  Anticipatory UPR Activation: A Protective Pathway and Target in Cancer.

Authors:  David J Shapiro; Mara Livezey; Liqun Yu; Xiaobin Zheng; Neal Andruska
Journal:  Trends Endocrinol Metab       Date:  2016-06-25       Impact factor: 12.015

4.  Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Authors:  Eric A Ariazi; Heather E Cunliffe; Joan S Lewis-Wambi; Michael J Slifker; Amanda L Willis; Pilar Ramos; Coya Tapia; Helen R Kim; Smitha Yerrum; Catherine G N Sharma; Emmanuelle Nicolas; Yoganand Balagurunathan; Eric A Ross; V Craig Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

5.  Avoiding the bad and enhancing the good of soy supplements in breast cancer.

Authors:  V Craig Jordan
Journal:  J Natl Cancer Inst       Date:  2014-09-04       Impact factor: 13.506

6.  Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.

Authors:  K Abdul-Wahab; D Corcoran; A Perachiotti; P D Darbre
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

Review 7.  Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Authors:  V Craig Jordan; Joan Lewis-Wambi; Helen Kim; Heather Cunliffe; Eric Ariazi; Catherine G N Sharma; Heather A Shupp; Ramona Swaby
Journal:  Breast       Date:  2007-08-24       Impact factor: 4.380

8.  MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors:  Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

9.  Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.

Authors:  Ping Fan; V Craig Jordan
Journal:  Steroids       Date:  2014-06-12       Impact factor: 2.668

10.  Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice.

Authors:  Y Iino; Y Takai; T Ando; N Sugamata; M Maemura; T Takeo; S Ohwada; Y Morishita
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.